Tilray Brands, Inc.(TLRY)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Tilray Brands, Inc. (TLRY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TLRY at 29.9/100 on a 32-signal composite quality model, placing it at rank #2,509 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (2.6) and balance sheet strength (3.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 32.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Tilray Brands, Inc. reports quarterly revenue of $206.7M, net income of $-26.6M. Top institutional holders of TLRY by reported 13-F value include Graham Capital Management, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, based on the most recent SEC filings. TLRY trades on the Nasdaq exchange and files with the SEC under CIK 1731348. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TLRY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tilray Brands, Inc. directly from SEC EDGAR.

AI Quality Score

29.9/100

AI Rank

#2,509

Revenue

$206.7M

Net Income

$-26.6M

TLRY key financials by period

Tilray Brands, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$821.3M$-2.2B
FY 202410-K$788.9M$-245.0M-22.1%
FY 202310-K$627.1M$-1.5B
FY 202210-K$628.4M$-476.8M-97.1%
FY 202110-K$513.1M$-367.4M-25.8%
FY 202010-K$405.3M$-102.5M-25.7%

Institutions holding TLRY

Institutional investors reporting a position in Tilray Brands, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Graham Capital Management, L.P.46,500,000$47.0M2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP4,007,600$18.0M2026-06-30
SIMPLEX TRADING3,361,600$15.1M2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP3,279,300$14.7M2026-06-30
DeepCurrents Investment Group13,050,000$13.1M2026-06-30
Toroso Investments2,498,656$11.2M2026-06-30
GROUP ONE TRADING, L.P.1,855,500$8.3M2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP1,021,777$4.6M2026-06-30
MORGAN STANLEY995,145$4.5M2026-06-30
CITADEL ADVISORS886,500$4.0M2026-06-30
TLRY

Tilray Brands, Inc.

TLRY
NasdaqSmall CapHealthcare

13F Pro Quality Score

29.9/100

Rank #2,509 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

60.5/100

Profitability

5.9/100

Balance Sheet

3.7/100

Earnings Quality

46.7/100

Free Cash Flow

17.2/100

Institutional Flow

2.6/100

Revenue Scale

47.2/100

Dilution Risk

32.9/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q1 2026
EDGAR

$206.73M

Net Income

Q1 2026
EDGAR

$-26.57M

EPS (Diluted)

Q1 2026
EDGAR

$-0.24

ROIC

Q1 2026
EDGAR

-6.7%

Top Institutional Holders

as of Q2 2026
$202.32M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…